PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsFactor vii deficiency
MeSH D005168 - factor vii deficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006474:Hemorrhagic disorders
1 Company
1 Drug
$
Success rate
D025861:Inherited blood coagulation disorders
27 Companies
2 Drugs
$
Success rate
D020147:Coagulation protein disorders
0 Companies
0 Drugs
Success rate
D005168: 
Factor vii deficiency
4 Companies
5 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novo NordiskEptacog alfa (activated) NovoSeven  1996-02-23   
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
1/1
Phase 3
100%
6/6
Approved: 5Overall Success rate: 100%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
CSL Behring
Lonoctocog alfa,
Albumin,
Bevifimod,
Coagulation factor viia recombinant human,
Rfviia,
Arm1,
Arm2
Novo Nordisk
Turoctocog alfa,
Eptacog alfa (activated),
Coagulation factor viia recombinant human,
Pcc
Octapharma
Simoctocog alfa
Pfizer
Nonacog alfa
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use